𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The ionic products of bioactive glass particle dissolution enhance periodontal ligament fibroblast osteocalcin expression and enhance early mineralized tissue development

✍ Scribed by Venu G. Varanasi; Jeremy B. Owyoung; Eduardo Saiz; Sally J. Marshall; Grayson W. Marshall; Peter M. Loomer


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
613 KB
Volume
98A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study resulted in enhanced collagen type 1 and osteocalcin expression in human periodontal ligament fibroblasts (hPDLF) when exposed to bioactive glass conditioned media that subsequently may promote early mineralized tissue development. Commercial Bioglass™ (45S5) and experimental bioactive coating glass (6P53‐b), were used to make a glass conditioned media (GCM) for comparison to control medium. ICP‐MS analysis showed increased concentrations of Ca^2+^, PO~4~^3−^, Si^4+^, and Na^+^, for 45S5 GCM and Mg^2+^, K^+^, Ca^2+^, PO~4~^3−^, Si^4+^, and Na^+^ for 6P53‐b GCM (relative to control medium). Differentiating hPDLF cultures exposed to 45S5 and 6P53‐b GCM showed enhanced expression of collagen type 1 (Col1α1, Col1α2), osteocalcin, and alkaline phosphatase gene expression. These GCM also enhanced osteocalcin protein expression. After 16 d of culture, 45S5 and 6P53‐b GCM treated cells showed regions of deep red Alizarin staining, indicating increased Ca within their respective extracellular matrices (ECM), while control‐treated cells did not exhibit these features. SEM analysis showed more developed ECM in GCM treated cultures, indicated by multiple tissue layering and abundant collagen fiber bundle formation, while control treated cells did not exhibit these features. SEM analysis showed polygonal structures suggestive of CaP in 45S5 GCM treated cultures. These results indicate the osteogenic potential of bioactive coating glass in periodontal bone defect filling applications. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011.